评估发展中国家整形与重建外科的经济影响:ReSurge经验
该研究回顾分析ReSurge International 2014至2017年在8个发展中国家的22次手术行程、756例手术干预,采用每避免一个伤残调整生命年(DALY)的成本评估成本效果,并用人力资本法做成本效益分析。结果显示成本效果范围为每避免一个DALY 52至11410美元,22次行程经济收益为9795384美元,21次行程按WHO选择成本效果干预阈值属极具成本效果或具成本效果。结论认为短期手术行程中的整形与重建手术在经济上可持续,高手术量和治疗复杂外科疾病的行程最具成本效果。
要点
- 22次行程中21次按WHO阈值属极具成本效果或具成本效果。
- 每避免一个DALY成本范围为52至11410美元。
- 高手术量及治疗复杂外科疾病的行程最具成本效果。
核心结论
- 该组织短期手术行程中开展的整形与重建手术在经济上可持续。
- 高手术量行程及治疗复杂外科疾病的行程最具成本效果。
- 为持续获得资金支持,向中低收入国家提供财政可持续的外科照护至关重要。
研究设计与样本
- 回顾性分析ReSurge International 2014至2017年手术行程的行程信息、成本与临床特征数据。
- 共纳入8个发展中国家的22次手术行程、756例手术干预。
- 采用每避免一个DALY的成本衡量成本效果,并以WHO选择成本效果干预阈值定义成本效果。
- 采用人力资本法进行成本效益分析。
主要发现
- 手术行程的成本效果范围为每避免一个DALY 52至11410美元。
- 22次手术行程的经济收益为9795384美元。
- 按WHO选择成本效果干预阈值,22次行程中21次属极具成本效果或具成本效果。
关键数值与推荐
- 成本效果以每避免一个DALY的成本表示,范围为52至11410美元。
- 成本效果判定采用WHO选择成本效果干预阈值。
- 22次行程中21次按上述阈值属极具成本效果或具成本效果。
临床怎么用
- 在发展中国家开展短期整形与重建手术行程时,可优先安排高手术量及治疗复杂外科疾病的行程以提升成本效果。
- 可依据每避免一个DALY的成本及WHO选择成本效果干预阈值评估此类行程的经济可持续性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As the global burden of disease continues to rise, it becomes increasingly important to determine the sustainability of specialty surgery in the developing world. The authors aim to (1) evaluate the cost-effectiveness of plastic and reconstructive surgery in the developing world and (2) quantify the economic benefit. METHODS: In this study, the authors performed a retrospective analysis of surgical trips performed by ReSurge International from 2014 to 2017. The organization gathered data on trip information, cost, and clinical characteristics. The authors measured the cost-effectiveness of the interventions using cost per disability-adjusted life-years and defined cost-effectiveness using World Health Organization Choosing Interventions That Are Cost-Effective thresholds. The authors also performed a cost-to-benefit analysis using the human capital approach. RESULTS: A total of 22 surgical trips from eight different developing countries were included in this study. The authors analyzed a total of 756 surgical interventions. The cost-effectiveness of the surgical trips ranged from $52 to $11,410 per disability-adjusted life-year averted. The economic benefit for the 22 surgical trips was $9,795,384. According to World Health Organization Choosing Interventions That Are Cost-Effective thresholds, 21 of the surgical trips were considered very cost-effective or cost-effective. CONCLUSIONS: Plastic and reconstructive operations performed during short-term surgical trips performed by this organization are economically sustainable. High-volume trips and those treating complex surgical conditions prove to be the most cost-effective. To continue to receive monetary funding, providing fiscally sustainable surgical care to low- and middle-income countries is imperative.
引用
- Nasser JS, Billig JI, Sue GR, et al. Evaluating the Economic Impact of Plastic and Reconstructive Surgical Efforts in the Developing World: The ReSurge Experience. Plast Reconstr Surg. 2019. PMID: 31461047. doi:10.1097/PRS.0000000000005984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。